Australia - Export of Heparin for Therapeutic Use
Since 2014, Australia Export of Heparin for Therapeutic Use decreased by 0.2% year on year. In 2019, the country was number 20 among other countries in Export of Heparin for Therapeutic Use with $6,702,333.73. Australia is overtaken by Switzerland, which was ranked number 19 with $12,350,596 and is followed by Belgium at $6,338,069.05. China lead the ranking with $1,237,456,257.9 in 2019, -3% compared to 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro witnessed the best average annual growth at +490.8% per year, while Greenland recorded the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 6,702,333.73 |
| 2018 | 7,080,908.00 |
| 2017 | 7,769,228.50 |
| 2016 | 6,034,967.00 |
| 2015 | 2,199,321.00 |
Download all data from 1988 to 2019
How does Australia rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data | |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data | |
| 19 |
#19
Switzerland
|
12,350,596.00 | 2019 | -66.0 % | -17.8 % | View data | |
| 20 |
#20
Australia
|
6,702,333.73 | 2019 | -5.3 % | -0.2 % | View data | |
| 21 |
#21
Belgium
|
6,338,069.05 | 2019 | -16.1 % | -8.7 % | View data | |